Sept. 13, 2007
Agilent Technologies has announced that Strand Life Sciences will develop its GeneSpring software in order to accelerate software upgrades. The agreement expands on a previous relationship between Strand and Stratagene, which was acquired by Agilent in June. The first Strand-developed version of GeneSpring GX is scheduled for release in 2007.
Applera Corporation has enlisted investment bank Morgan Stanley to advise a restructuring of the Applied Biosystems and Celera groups currently traded under the parent company. Applera is exploring alternatives to the current structure including listing the two groups as publicly traded companies.
Caliper Life Sciences has announced that Novartis has signed a multi-year license to Caliper’s patented non-invasive optical imaging methods. The announcement follows Caliper’s notification of allowance of patent claims for conjugate fluorescence imaging methods.
GENOMIC EXCELLENCE AWARDS
The National Human Genome Research Institute awarded around $30 million to the Dana Farber Cancer Institute and Stanford University under its Centers of Excellence in Genomic Science program. The five-year awards will provide around $16 million to Dana Farber to create a new Center of Excellence and around $14 million for an existing center at Stanford.
The Public Health Agency of Canada (PHAC), Winnipeg, Manitoba has liscensed DNASTAR’s Lasergene sequence analysis software for use on the Winnipeg campus of PHAC.
Subscribe to Bio-IT World magazine.